tajdistributors.adm@yahoo.com - GST NO. : 33ACGPF5198L1ZB
2 Box (MOQ)
| Business Type | Exporter, Supplier, Trader |
| Form | Tablets |
| Type Of Medicines | Allopathic |
| Strength | 80 mg |
| Click to view more | |
Product Details
Treatment
Cancer
Composition
Osimertinib
Country of Origin
India
Storage
Cool & Dry Place
Generic Name
Tagrisso
It is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R mutations, as detected by an FDA-approved test. TAGRISSO is indicated for the treatment of patients with metastatic EGFR T790M mutation-positive NSCLC, as detected by an FDA-approved test, whose disease has progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy.
Looking for "Osimertinib Tablets" ?
Box
